Anthera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 19   

Articles published

ANTH 2.54 +0.02 (0.79%)
price chart
Anthera Pharmaceuticals (ANTH) Sees Hammer Chart Pattern: Time to Buy?
Anthera Pharmaceuticals Inc (ANTH - Snapshot Report) has been struggling lately, but the selling pressure may be coming to an end soon.
Anthera Pharmaceuticals (ANTH) Sees Hammer Chart Pattern: Time to Buy ...  NASDAQ
Fast Moving Stocks : Anthera Pharmaceuticals (NASDAQ:ANTH), SunEdison ...  Tech News
Related articles »  
Anthera Pharmaceuticals Hits New 12-Month Low at $2.39 (ANTH)
Anthera Pharmaceuticals logo Anthera Pharmaceuticals (NASDAQ:ANTH) reached a new 52-week low on Thursday , American Banking News reports.
Investors Are Watching : RiT Technologies (NASDAQ:RITT), Anthera ...
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) traded 56844 shares and its share price decreased -0.38% to close at $2.65.
Related articles »  
Hot News : Anthera Pharmaceuticals (NASDAQ:ANTH), Exxon Mobil (NYSE ...
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Active Stocks : AOL Inc. (NYSE:AOL), Tyson Foods (NYSE:TSN), eLong Inc ...
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) studied sPLA2 inhibition for acute coronary syndrome also using LY315920NA/S-5920, but the trial failed in Phase III.
Hot Stocks: Banco Santander (NYSE:BSBR), Staples (NASDAQ:SPLS ...
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), on 28 July announced financial results and operational update for the second quarter ended June 30, 2014.
Why Agenus (AGEN) Could Be Positioned for a Slump
If you are still interested in the Med-Biomed/Gene sector, you may instead consider some better-ranked stocks including Actelion Ltd.
Insmed (INSM) Falls: Stock Tanks 26.6%
Insmed Incorporated (INSM - Snapshot Report) saw a big move last session, as the company's shares fell by nearly 27% on the day.
Related articles »  
Don't Miss : GTT Communications (NYSEMKT:GTT), Receptos (NASDAQ:RCPT ...
On AUG 4, Anthera Pharmaceuticals Inc (NASDAQ:ANTH) has been struggling lately, but the selling pressure may be coming to an end soon.
Biotech Stock Directory Update
Anthera Pharmaceuticals Inc. (NasdaqGM:ANTH) is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases.